Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
G. Adair Smith
Observed names:
G A Smith,
G Smith,
G. Smith,
Garrett A. SMith
Institution:
Huntsman Cancer Institute
Observed institutions:
University of California, San Francisco,
Huntsman Cancer Institute,
Clatterbridge Cancer Centre NHS Foundation Trust
OpenAlex ID:
A5012015271
High-dose cytarabine dose modification reduces the incidence of neurotoxicity in patients with renal insufficiency.
1997
·
G A Smith
, L E Damon
, et al.
·
Journal of Clinical Oncology
·
90
Current status of vinorelbine for breast cancer.
1995
·
G A Smith
·
PubMed
·
37
New treatments for breast cancer.
1996
·
G Smith
, I C Henderson
·
PubMed
·
36
EP-2173 Bladder filling in patients undergoing prostate radiotherapy on the MR-linac
2019
·
G. Adair Smith
, T. Herbert
, et al.
·
Radiotherapy and Oncology
·
1
PDF
NOVEMBER, A Phase II Trial of a 9 Day Course of Whole Breast Radiotherapy for Early-Stage Breast Cancer
2024
·
M.M. Poppe
, K. Boucher
, et al.
·
International Journal of Radiation Oncology*Biology*Physics
PH-0164 Abdominal compression; development of a non-gated pancreas MRIgRT workflow
2021
·
S. Alexander
, R. Lawes
, et al.
·
Radiotherapy and Oncology
PO-1828: Alignment of prostate cancer patients for radiotherapy on the MR-linac
2020
·
H. Barnes
, J. Mohajer
, et al.
·
Radiotherapy and Oncology
EP-2078: PROSPECT: Phase 2 rescanning of seromas in patients to evaluate CTV reduction in breast cancer
2016
·
G. Smith
, P. Robson
, et al.
·
Radiotherapy and Oncology
PDF
Utilization of An NCI Infrastructure to Evaluate Breast Cancer Patient Outcomes of Importance in Determining Priorities for New Health Care Reform.
1997
·
Garrett A. SMith
, I. C. Henderson
·
Defense Technical Information Center (DTIC)
Show more works
View as search
Works count:
9
Citation count:
164
H-index:
3
I10-index:
3
Year
Topic
Type